Bayer buys glaucoma drugmaker in 2.45 bln-dollar deal
African Insider | 06.05.2026 15:43Frankfurt – German agrichemical and pharmaceutical giant Bayer said Wednesday it would buy experimental glaucoma drug maker Perfuse Therapeutics in a deal worth up to $2.45 billion (2.09 billion euros).
